Skip to content

Clinical trials

Phase 3 Sarcoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 3 Country / region: Germany Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20082
20091
20101
20113
20151
20172
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Alaunos Therapeutics1
Eisai Inc.1
Eli Lilly and Company1
GlaxoSmithKline1
Intensity Therapeutics, Inc.1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Philogen S.p.A.1
Rain Oncology Inc1
Technical University of Munich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma17
Liposarcoma6
Histiocytoma, Malignant Fibrous5
Leiomyosarcoma5
Rhabdomyosarcoma5
Sarcoma, Synovial5
Fibrosarcoma4
Hemangiosarcoma4
Neurofibrosarcoma4
Endometrial Neoplasms1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.